Why does NIH budget get cut in 2027?

White House proposes major NIH and HHS cuts

The White House has asked Congress to reduce funding for the National Institutes of Health (NIH) by $5 billion in its 2027 budget request, and to downsize the number of NIH institutes and centers from 27 to 22. A parallel proposal would cut overall spending for the Department of Health and Human Services (HHS) by more than 12%.

The practical impact of an NIH cut would be felt across biomedical research—everything from early-stage studies to clinical trials—because NIH is a central federal funder of work that supports new drugs, devices, and public-health interventions. The proposed restructuring into fewer institutes and centers would also change how research priorities are organized and managed inside the agency.

Congress’s likely reaction matters, because the budget proposals are not final policy. The story indicates Congress is unlikely to fully go along with the proposed NIH reductions. That means the final level of funding and any structural changes could differ from what the White House put forward.

This is closely tied to broader federal health-agency funding pressures: another report describes the White House request seeking a larger cut to HHS. Taken together, the proposals signal a push toward shrinking federal health research and services budgets, at least in the starting position for 2027 negotiations.

For patients and clinicians, the stakes are indirect but real: fewer research resources can slow the pipeline of new evidence and treatments, while organizational changes can alter which programs receive attention. The near-term news is therefore less about an immediate clinical effect and more about whether lawmakers will reverse, moderate, or redesign the proposed reductions.